147 related articles for article (PubMed ID: 26421912)
21. Menopausal hormone use and endometrial cancer, by tumor grade and invasion.
Shapiro JA; Weiss NS; Beresford SA; Voigt LF
Epidemiology; 1998 Jan; 9(1):99-101. PubMed ID: 9430277
[TBL] [Abstract][Full Text] [Related]
22. Hormone therapy and different ovarian cancers: a national cohort study.
Mørch LS; Løkkegaard E; Andreasen AH; Kjaer SK; Lidegaard O
Am J Epidemiol; 2012 Jun; 175(12):1234-42. PubMed ID: 22517811
[TBL] [Abstract][Full Text] [Related]
23. A population-based cohort study on the use of hormone treatment and endometrial cancer in southern Sweden.
Epstein E; Lindqvist PG; Olsson H
Int J Cancer; 2009 Jul; 125(2):421-5. PubMed ID: 19326453
[TBL] [Abstract][Full Text] [Related]
24. Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
Allen NE; Tsilidis KK; Key TJ; Dossus L; Kaaks R; Lund E; Bakken K; Gavrilyuk O; Overvad K; Tjønneland A; Olsen A; Fournier A; Fabre A; Clavel-Chapelon F; Chabbert-Buffet N; Sacerdote C; Krogh V; Bendinelli B; Tumino R; Panico S; Bergmann M; Schuetze M; van Duijnhoven FJ; Bueno-de-Mesquita HB; Onland-Moret NC; van Gils CH; Amiano P; Barricarte A; Chirlaque MD; Molina-Montes ME; Redondo ML; Duell EJ; Khaw KT; Wareham N; Rinaldi S; Fedirko V; Mouw T; Michaud DS; Riboli E
Am J Epidemiol; 2010 Dec; 172(12):1394-403. PubMed ID: 20961969
[TBL] [Abstract][Full Text] [Related]
25. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
Bakken K; Alsaker E; Eggen AE; Lund E
Int J Cancer; 2004 Oct; 112(1):130-4. PubMed ID: 15305384
[TBL] [Abstract][Full Text] [Related]
29. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.
Crosbie EJ; Zwahlen M; Kitchener HC; Egger M; Renehan AG
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3119-30. PubMed ID: 21030602
[TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
31. A Danish nationwide study of risk factors associated with Type I and Type II endometrial cancer.
Faber MT; Sperling CD; Bennetsen AKK; Aalborg GL; Kjaer SK
Gynecol Oncol; 2021 May; 161(2):553-558. PubMed ID: 33608145
[TBL] [Abstract][Full Text] [Related]
32. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
33. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
Jamin C; Bourg F; Legeai J; Senoussi S
Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
[TBL] [Abstract][Full Text] [Related]
34. Risk of endometrial cancer among women with benign ovarian tumors - A Danish nationwide cohort study.
Reinholdt K; Kjaer SK; Guleria S; Frederiksen K; Mellemkjær L; Munk C; Jensen A
Gynecol Oncol; 2020 May; 157(2):549-554. PubMed ID: 32139149
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and endometrial cancer.
Emons G; Huschmand-Nia A; Krauss T; Hinney B
Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
[TBL] [Abstract][Full Text] [Related]
36. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
38. Type of hormone therapy and risk of misclassification at mammography screening.
Njor SH; Hallas J; Schwartz W; Lynge E; Pedersen AT
Menopause; 2011 Feb; 18(2):171-7. PubMed ID: 20729766
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
40. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
